Final answer:
The purpose of the Combat Methamphetamine Epidemic Act of 2005 is to regulate the sale of products containing pseudoephedrine and ephedrine, in an effort to curb the manufacture and abuse of methamphetamine.
Step-by-step explanation:
The purpose of The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is a) To regulate the sale of products containing pseudoephedrine and ephedrine.
The CMEA was enacted to combat the abuse and trafficking of methamphetamine by regulating the over-the-counter sales of medications that contain ephedrine, pseudoephedrine, and phenylpropanolamine, substances that can be used to manufacture methamphetamine.
The act places restrictions on the amount one could purchase and mandates that buyers show identification and sign a logbook, among other regulatory requirements designed to curb the making of methamphetamine.
Methamphetamine is a powerful psychostimulant with potentially severe addictive properties and health risks, prompting control through legislations like the CMEA.
The purpose of The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is to regulate the sale of products containing pseudoephedrine and ephedrine. These compounds are commonly found in over-the-counter cold and flu remedies and can be used as ingredients in the production of methamphetamine.
The act aims to make obtaining pseudoephedrine more difficult in order to combat the widespread use of methamphetamine.